Imaging– tag –
-
Multimodal Nanomaterials for Prostate Cancer Theranostics Advance, Integrating Precision Diagnosis and Therapy with PSMA-Targeted Platforms
International Journal of Nanomedicine (IJN) International Overview Research into multimodal nanomaterials for prostate cancer (PCa) theranostics is progressing, offering versatile platforms that integrate molecular imaging, biomarker det... -
Virus-Inspired Nanoparticles Revolutionize Drug and Gene Delivery, Overcoming Biological Barriers and Enhancing Cell-Specific Targeting for New Therapies
PMC International Overview Virus-inspired nanoparticles are emerging as a promising strategy for advanced drug and gene delivery. Viruses exhibit exceptional efficiency in overcoming biological barriers, targeting specific cells, and ind... -
Redox-Responsive Theranostic Nanoplatforms Targeting Tumor Microenvironment Revolutionize Cancer Diagnosis and Treatment
MDPI Switzerland Overview Redox-responsive theranostic nanoplatforms, leveraging unique biological features of the tumor microenvironment, are gaining attention as an innovative approach to integrate cancer diagnosis and therapy. These n... -
CoolLED Spotlights Advanced Multi-Color Imaging Biosensors Enabling Single-Molecule Detection with High Throughput and Sensitivity
CoolLED UK Overview CoolLED highlighted an article discussing a novel biosensor concept that achieves single-molecule imaging with high throughput and sensitivity using a multi-color imaging setup. This advanced biosensor technology sign... -
Exosens Revenue up 15.3%, Acquires Emberion to Strengthen Advanced Imaging with Quantum Dot Technology
Exosens France Overview Exosens reported a 15.3% revenue increase in H1 2026, driven by demand in defense imaging and night vision. Leveraging this growth, Exosens acquired Emberion on April 24, 2026, to bolster its position in advanced ... -
Nanotechnology Advances Early Diagnosis and Targeted Therapy for Ovarian Cancer, Significantly Improving Patient Quality of Life
MDPI Switzerland Overview This article discusses rapid advancements in nanotechnology for ovarian cancer management, focusing on early diagnosis and targeted therapy. Nanoparticles, engineered at the 1–100 nm scale, possess unique proper... -
Manganese-Doped Carbon Nanodots Show Promise as Next-Generation Dual-Modal MRI and Fluorescence Imaging Agents
ACS Nano (ACS Publications) USA Overview This study explores manganese-doped carbon nanodots (CNDs) as next-generation dual-modal imaging agents for MRI and fluorescence imaging. CNDs offer intrinsic fluorescence, excellent biocompatibil... -
Nanotechnology Revolutionizes Cancer Theranostics: Precision Targeting Achieved with Radioligand Therapy Integration
J Clin Oncol Ther / Scholars Literature International Overview This review highlights nanotechnology's role in enhancing theranostic efficacy in oncology, especially when combined with radioligand therapy. Nanoparticles like gold, iron o... -
Histidine-Derived Carbon Dots Enable Bioimaging of Lipid Vesicles and White-Light Emission
ACS Publications USA Overview Researchers have successfully synthesized histidine-derived carbon dots (His-CDs) under pH-mediated conditions, demonstrating their utility for bioimaging of lipid vesicles and white-light-emitting applicati... -
AI-Augmented Organ- and Organoid-on-a-Chip Technologies Accelerate Drug Screening, Enhancing Reproducible and Pharmacologically Interpretable Readouts
Lab on a Chip (Royal Society of Chemistry) UK Overview A new article in 'Lab on a Chip' highlights the increasing role of artificial intelligence (AI) in augmenting organ- and organoid-on-a-chip technologies for drug screening. AI is emp...
